Abstract
Surveillance of antibiotic resistance has become a public global concern after the rapid worldwide dissemination of several antibiotic resistance genes. Here we report the role of the Institut Hospitalo-Universitaire Méditerranée Infection created in 2011 in the identification and description of multidrug-resistant bacteria thanks to collaborations and training of students from the Mediterranean basin and from African countries. Since the creation of the institute, 95 students and researchers have come from 19 different countries from these areas to characterize 6359 bacterial isolates from 7280 samples from humans (64%), animals (28%) and the environment (8%). Most bacterial isolates studied were Gram-negative bacteria (n = 5588; 87.9%), mostly from Algeria (n = 4190), Lebanon (n = 946), Greece (n = 610), Saudi Arabia (n = 299) and Senegal (n = 278). Antibiotic resistance was diversified with the detection and characterization of extended-spectrum β-lactamases, carbapenemases and resistance to colistin, vancomycin and methicillin. All those studies led to 97 indexed international scientific papers. Over the last 6 years, our institute has created a huge network of collaborations by training students that plays a major role in the surveillance of resistance to antibiotics in these countries.
Highlights
During the last decade, antibiotic resistance has become one of the major public health priorities in the world [1] because of the emergence of new mechanisms of resistance
Since the creation of this institute, the JMR team has welcomed a total of 126 students or visiting scientists, including 95 deduplicated students (75.4%) from academic exchanges with 19 countries from the Mediterranean basin, Africa and Middle East
We show the unique role of Institut Hospitalo-Universitaire Méditerranée Infection (IHU-MI) in training about 100 students working in the field of antibiotic resistance from the Mediterranean basin and Africa over the last 6 years
Summary
Antibiotic resistance has become one of the major public health priorities in the world [1] because of the emergence of new mechanisms of resistance. Recent epidemiologic data from our institution demonstrate that the level of antibiotic resistance for the most common bacterial species of clinical interest did not significantly change over the last 15 years in Marseille, France [3,4]. Data on the level of antibiotic resistance in Europe show disparities between countries and bacterial species for certain antibiotics; for example, resistance to carbapenems is much more frequent in Romania, Italy and Greece [3]. It appears from those studies that a better understanding and surveillance of antibiotic resistance at the local and national levels is critical to manage antibiotic-resistant bacterial infections in the future [5]. Data on antibiotic resistance and surveillance of the emergence and spread of new mechanisms of resistance in the Mediterranean basin and in African countries were lacking in most of those countries until now
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
